CART-based targeting of solid tumors remains a considerable and worthwhile challenge in the field of immunotherapy. The role of chemotherapy to target stroma and enhance CAR cell anti-tumor function, expansion and persistence is still unresolved
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2Be3Fkq
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου